About the Study : In this cohort study using nationwide Medicaid data, Black pregnant females with opioid use disorder (OUD) had higher discontinuation rates than White females for buprenorphine treatment during pregnancy and through 1 year postpartum, with less pronounced disparities for methadone. Findings suggest persistent racial and ethnic inequities in treatment retention during and after pregnancy.
Explore JAMA+ Women's Health for more Women's Health research, commentary, multimedia, and resources. Led by Editor in Chief Linda Brubaker, MD, JAMA+ Women's Health is a curated source of trusted clinical information that advances health care for women worldwide. Dr Brubaker is also a JAMA Deputy Editor.
Corresponding Author : Heidi Zakoul, MPH, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 399 Revolution Dr, Ste 920, Somerville, MA 02145 ( hzakoul@bwh.harvard.edu ).
10.1001/jamapsychiatry.2026.2506
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
JAMA Psychiatry